cancer cancer guidelines clinical trials cancer patients oncology cancer physicians cancer hospitals oncology
NCCN - National Comprehensive Cancer Network National Comprehensive Cancer Network Homepage Patients with Cancer Cancer Clinicians Cancer Industry About National Comprehensive Cancer Network

 

Contact Us / Privacy Policy

Clinicians

Interactive Learning

Download Podcast

Listen to MP3

Podcast Evaluation


Go back to previous page

 

 

     
 

Prophylactic Therapy: Identifying Patients at Risk for Fever and Neutropenia

Download Podcast

Listen to MP3

Podcast Evaluation

A presentation from the NCCN 2007 Nursing Program: Role of the Advanced Practice Nurse in Quality Oncology Care™ held in Hollywood, Florida, on March 14, 2007

Presenter

Christopher Friese, RN, PhD, AOCN
Dana-Farber Cancer Institute
Boston, Massachusetts

Faculty Disclosure Statement

Dr. Friese has disclosed that he has financial interests, arrangements, or affiliations with the manufacturer of products and devices to be discussed in his presentation or who may financially support the educational activity. He has received honoraria as a speaker and for advisory board participation for Amgen Inc.  He is also a stockholder in Amgen Inc. and Novartis Pharmaceuticals Coporation.  Dr. Friese has indicated that his presentation will include discussion of investigational or unlabeled uses of pegfilgrastim, filgrastim, and various anti-infectives and antifungals.

Program Overview

The NCCN 2007 Nursing Program is designed to provide advanced practice oncology nurses with information on a variety of topics integral to quality cancer care. It consists of several presentations focused on the complexities of cancer care, symptom management and supportive care issues, and leading strategies to advance nursing research. This presentation will focus on fever and neutropenia, a serious complication from cancer-related therapy that can lead to significant morbidity. This presentation will describe the clinical significance of fever and neutropenia, the patient-related and therapy-related factors which increase the risk for fever and neutropenia, and current options for prophylactic therapy.

Educational Objectives

Following this activity, participants should be able to do the following:

  • Describe the clinical significance of fever and neutropenia for patients with cancer
  • Summarize patient-related and therapy-related factors that can increase the risk for the development of fever and neutropenia
  • Identify current options for the prophylactic management of fever and neutropenia

Intended Audience

This educational activity is designed to meet the educational needs of advanced practice nurses who manage patients with cancer.

Activity Instructions

Contact hours will be awarded to participants who listen to the presentation and complete the evaluation.  Participants should review the learning objectives and faculty disclosure statements prior to listening to a presentation in its entirety.  You must be connected to the Internet in order to review and complete the evaluation form.  A certificate of completion will be electronically generated once you complete the evaluation form.  To receive contact hours, this activity must be completed no later than August 29, 2008.  There is no fee for participating in this activity.

Download Podcast

Listen to MP3

Podcast Evaluation

Accreditation Information

Nurses

This activity is approved for 1.1 contact hours.  National Comprehensive Cancer Network is an approved provider of continuing nursing education by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Release date:  August 29, 2007
Expiration date:  August 29, 2008

Commercial Support

Distribution supported by educational grants from Amgen Oncology, Eli Lilly and Company, and Merck Oncology

 

Educational Opportunities

NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™

September 4, 2008
New York Marriott at the Brooklyn Bridge
New York, New York

NCCN 3rd Annual Congress: Hematologic Malignancies™

September 5 – 6, 2008
New York Marriott at the Brooklyn Bridge
New York, New York


Exhibitor Information


NCCN Regional Guidelines Symposia

NCCN Non-Small Cell Lung Cancer Guidelines Symposium
Birmingham, Michigan (Friday, September 12, 2008)

NCCN Breast Cancer Guidelines Symposium
Durham, North Carolina (Monday, September 22, 2008)

NCCN Colon and Rectal Cancers Guidelines Symposia
New York , New York (Tuesday, September 23, 2008)

NCCN Head and Neck Cancers Guidelines Symposia
Omaha, Nebraska (Friday, October 10, 2008)

NCCN Breast Cancer Guidelines Symposium
Tampa, Florida (Monday, October 20, 2008)

NCCN Non-Small Cell Lung Cancer Guidelines Symposium
Durham, North Carolina (Monday, November 03, 2008)

More Events ....


NCCN International

Chinese – 中文

Japanese –日本語

NCCN Privacy Policy NCCN Legal Disclaimer NCCN Site Map Contact NCCN Home National Comprehensive Cancer Network